Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients

Riquelme, AJ; Calvo MA; Guzman, AM; Depix, MS; Garcia P.; Pérez, C.; Arrese M.; Labarca, JA

Abstract

Saccharomyces boulardii is widely used as a probiotic compound. Clinical data suggest that this agent is safe and effective. We report two cases of fungemia caused by S. cerevisiae occurring in immunosuppressed patients treated orally with S. boulardii. Molecular typing confirmed clonality in isolate strains from patients and the S. boulardii capsule. Physicians caring for immunosuppressed patients must be aware of this potential serious complication of probiotic use.

Más información

Título según WOS: Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients
Título según SCOPUS: Saccharomyces cerevisiae fungemia after Saccharomyces boulardii treatment in immunocompromised patients
Título de la Revista: JOURNAL OF CLINICAL GASTROENTEROLOGY
Volumen: 36
Número: 1
Editorial: LIPPINCOTT WILLIAMS & WILKINS
Fecha de publicación: 2003
Página de inicio: 41
Página final: 43
Idioma: English
URL: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00004836-200301000-00013
DOI:

10.1097/00004836-200301000-00013

Notas: ISI, SCOPUS